US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market to Grow at a CAGR of 7.2% to reach US$ 733.71 million from 2022 to 2030
The US Fluorescence In-Situ Hybridization (FISH) Imaging Systems market is expected to grow from US$ 419.74 million in 2022 and is expected to reach a value of US$ 733.71 million by 2030; it is anticipated to record a CAGR of 7.2% from 2022 to 2030.
Market Insights and Analyst View:
Fluorescence in situ hybridization (FISH) is a molecular technique for cytogenetic analysis. This technique uses fluorescent probes that bind to only particular parts of a nucleic acid sequence with a high degree of sequence complementarity. FISH detects the presence or absence of specific DNA sequences on chromosomes. FISH is often used to find specific features in DNA/RNA targets for medicine, genetic counseling, and species identification. Key factors driving the fluorescence in-situ hybridization (FISH) imaging systems market growth include the rising prevalence of target disorders and increasing R&D investments in in-vitro diagnostics. However, the high cost of FISH imaging systems and procedures hinders the market growth.
Growth Drivers and Restraints:
FISH is a powerful molecular cytogenetic technique that allows the visualization and localization of specific DNA sequences within cells or tissues. This technology has revolutionized the field of genetics and diagnostics, providing researchers and clinicians with valuable insights into genetic abnormalities, chromosomal rearrangements, and various diseases. The increasing prevalence of target disorders such as genetic syndromes, cancer, and other genetic anomalies drives the demand for FISH imaging systems. According to the National Library of Medicine, the US is expected to record 1.96 new cancer cases and 609,820 cancer deaths in 2023. The demand for accurate and reliable diagnostic tools surges with the continued rise in the prevalence of these target disorders. FISH imaging systems provide high-resolution images to aid the detection of subtle genetic changes, enabling early disease diagnosis and personalized treatment approaches. These disorders often involve genetic mutations or variations that can be accurately identified and characterized using FISH imaging systems. The ability to precisely map the location of specific genes or DNA sequences within cells has proven crucial for understanding disease mechanisms, developing targeted therapies, and making informed clinical decisions.
A prominent advantage of FISH lies in its ability to work with various sample types, including formalin-fixed paraffin-embedded tissues, cytological preparations, and fresh tissues. This versatility has made FISH an essential tool in both research and clinical settings, allowing the identification of genetic markers associated with diseases such as leukemia, lymphoma, solid tumors, and congenital disorders.
The fluorescence in situ hybridization (FISH) imaging systems market is further driven by continued investments in research and development (R&D) activities related to in-vitro diagnostics (IVD). With its unique capability to visualize specific DNA sequences within cellular environments, the FISH technique has emerged as a key procedure in modern diagnostics, particularly in detecting genetic disorders and rare diseases. An upsurge in R&D funding in IVD has catalyzed transformative advancements in FISH imaging systems by allowing researchers to create cutting-edge platforms providing enhanced image quality with features supporting streamlined automation, culminating in more accurate and rapid diagnostic processes. PNA FISH, a novel diagnostic method that uses FISH with peptide nucleic acid (PNA) probes, combines the ease of traditional staining procedures with the exceptional performance of PNA probes to provide rapid and accurate diagnoses of contagious diseases, which makes PNA FISH suitable for routine application and enables clinical microbiology laboratories to report important information for patient therapy within a time frame that is not possible using classic biochemical methods.
However, FISH imaging analysis is a less commonly used method in cancer detection owing to its relatively higher cost than other methods. In addition to the equipment cost, the expenses associated with reagents, other consumables, and specialized personnel appointments can add to the overall cost of evaluation based on FISH imaging. For instance, the detection of ALK gene non-small cell lung cancer by IHC costs US$ 90.07 in the US for every test, which is less than either independent or parallel testing by FISH and IHC (costing ~US$ 441.85 in the US). Thus, the high cost of procedures and systems limits the growth of the fluorescence in situ hybridization (FISH) imaging systems market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market: Strategic Insights
Market Size Value in US$ 419.74 million in 2022 Market Size Value by US$ 733.71 million by 2030 Growth rate CAGR of 7.2% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market: Strategic Insights
![us-fluorescence-in-situ-hybridization-fish-imaging-systems-market](https://www.theinsightpartners.com/assets/rdimages/us-fluorescence-in-situ-hybridization-fish-imaging-systems-market-img1.png)
Market Size Value in | US$ 419.74 million in 2022 |
Market Size Value by | US$ 733.71 million by 2030 |
Growth rate | CAGR of 7.2% from 2022 to 2030 |
Forecast Period | 2022-2030 |
Base Year | 2022 |
![Analyst Image](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst Image](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
Report Segmentation and Scope:
The “US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market” is segmented on the basis of the product, application, and end user. Based on product, the market is segmented into instruments, consumables, accessories, and software. In terms of application, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnosis, and others. Based on end user, the market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
The US fluorescence in-situ hybridization (FISH) imaging systems market, by product, is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Consumables are the most promising segment of the fluorescence in-situ hybridization (FISH) imaging system market that will contribute to tremendous growth in the coming years. FISH consumables include hybridization buffers, probes, tag detection kits, signal amplification detection kits, and others. The presence of manufacturers such as Abbott, F. Abnova, and Thermo Fisher Scientific bolsters the market for the consumables segment. These products are frequently used in various research diagnosis processes, which is expected to propel consumption. Thus, the presence of various market players offering probes & kits and technological advancements by market players are likely to propel the market for the segment in the coming years.
Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Products – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on application, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnosis, and others. The cancer diagnosis segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. FISH technology has tremendously benefited cancer diagnosis. FISH imaging systems can look for gene changes and help detect anomalies. According to Cancer Research UK, FISH testing is used for the diagnosis of several cancers, including breast cancer, lymphoma, lung cancer, prostate cancer, chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloma, Ewings sarcoma, and melanoma skin cancer.
Based on end user, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organization, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. The diagnostic laboratories are involved in various research projects to develop several technologies and products for fluorescence in-situ hybridization (FISH) imaging processes. Unprecedented developments in research and technologies have created the potential for transformation in the healthcare and life sciences sectors. The clinical applications of fluorescence in-situ hybridization (FISH) imaging systems are vast and offer opportunities to enhance diagnosis and treatment capabilities for chronic disease. They offer huge potential in gene discovery and diagnosis of rare genetic disorders. The technologies are increasingly used to analyze rare and common genetic factors influencing the development of common diseases, such as cancer, high blood pressure, diabetes, and renal diseases.
Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Opportunity:
FISH imaging systems are witnessing a remarkable evolution due to the surge in technological advancements, which result in cutting-edge innovations transforming the landscape of genetic research and diagnostics. These advancements include enhanced optics, more sensitive and versatile fluorophores, and sophisticated automation features. Modern FISH imaging systems, integrated with these upgraded features, offer greater sensitivity, improved image resolution, and faster processing times. Moreover, these technological advancements have extended the application scope of FISH imaging from cancer diagnosis to genetic predisposition testing. In April 2023, Agilent Technologies Inc had formed a partnership with PathAI. The partnership enabled the Agilent and PathAI to build integrated solutions with assays and machine learning analysis algorithms. Similarly, in May 2023, Pfizer and Thermo Fisher Scientific Inc entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries across Latin America, Africa, the Middle East, and Asia where advanced genomic testing was previously limited or unavailable. Access to local NGS testing can help enable faster analysis of related genes, allowing healthcare providers to choose the best medicine for that specific patient. Thus, technological advancements in FISH imaging systems create significant opportunities for companies in the fluorescence in situ hybridization (FISH) imaging systems market.
Country Analysis:
The US is estimated to hold the largest fluorescence in-situ hybridization (FISH) imaging systems market share during the forecast period. The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer fuel the adoption of fluorescence in-situ hybridization (FISH) imaging systems in the US. As per data published by the American Cancer Society in 2022, nearly 1.9 million cancer cases were diagnosed and 609,360 cancer deaths were reported in the US. These systems offer high-resolution imaging of genetic material, enabling researchers and clinicians to detect chromosomal abnormalities and gene mutations with greater accuracy. Furthermore, the increasing focus on personalized medicine and targeted therapies has led to an upsurge in research activities involving genetic analysis, bolstering the demand for FISH imaging systems. The ability of these systems to provide detailed spatial information on gene sequences directly within cells has proven invaluable in both research and clinical applications. The FISH imaging systems have recently gained immense popularity due to their technological advancements such as improved automation, higher throughput, and enhanced image analysis software. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently. Thus, the growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer bolster the fluorescence in-situ hybridization (FISH) imaging systems market in the US.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the US fluorescence in-situ hybridization (FISH) imaging systems market are listed below:
- In May 2023, Pfizer and Thermo Fisher Scientific Inc collaborated to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries across Latin America, Africa, the Middle East, and Asia where advanced genomic testing was previously limited or unavailable. Access to local NGS testing can help enable faster analysis of related genes, allowing healthcare providers to choose the best medicine for that specific patient.
- In April 2023, Agilent Technologies Inc signed a memorandum of understanding with Theragen Bio in South Korea. As part of the partnership agreement, Agilent and Theragen Bio combined their strengths in cancer genomic profiling design, engineering knowledge, and software expertise to drive localized analysis capabilities and accelerate treatment decisions.
- In January 2023, Thermo Fisher Scientific Inc, the world leader in serving science, had completed its acquisition of The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by Nordic Capital in an all-cash transaction valued at GBP 2.3 billion, or US$ 2.8 billion at current exchange rates. The Binding Site adds pioneering innovation in diagnosis and monitoring for multiple myeloma to the existing specialty diagnostics portfolio. Early detection and informed treatment decisions can substantially impact patient outcomes.
- In December 2021, BioGenex Laboratories Inc launched three new primary immunohistochemistry (IHC) antibodies for cancer diagnostics—CD8A, CD56, and CD163.
- In April 2021, Applied Spectral Imaging (ASI) and KromaTiD Inc had entered a strategic commercial partnership, allowed ASI worldwide rights to market KromaTiD’s proprietary Pinpoint FISH (PPF) probes and assay services.
Competitive Landscape and Key Companies:
Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, Applied Spectral Imaging, and PerkinElmer Inc are among the prominent players operating in the fluorescence in-situ hybridization (FISH) imaging systems market. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
Product, Application, and End User
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Fluorescence in situ hybridization (FISH) is a molecular technique for cytogenetic analysis. This technique uses fluorescent probes that bind to only particular parts of a nucleic acid sequence with a high degree of sequence complementarity. FISH detects the presence or absence of specific DNA sequences on chromosomes. FISH is often used to find specific features in DNA/RNA targets for medicine, genetic counseling, and species identification.
Factors such as the rising prevalence of target disorders and the increasing R&D investments in in-vitro diagnostics propel market growth.
The fluorescence in-situ hybridization (FISH) imaging systems market majorly consists of the players, including Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, Applied Spectral Imaging, and PerkinElmer Inc.
The fluorescence in-situ hybridization (FISH) imaging systems market was valued at US$ 419.74 million in 2022.
The fluorescence in-situ hybridization (FISH) imaging systems market, by end user, is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR.
The fluorescence in-situ hybridization (FISH) imaging systems market is expected to be valued at US$ 733.71 million in 2030.
The US fluorescence in-situ hybridization (FISH) imaging systems market, by application, is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnosis, and others. The cancer diagnosis segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR.
The fluorescence in-situ hybridization (FISH) imaging systems market, by services, is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held a larger market share in 2022. Also, the same segment is anticipated to register a higher CAGR.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 US PEST Analysis
5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Target Disorders
5.1.2 Increasing R&D Investments in In-Vitro Diagnostics
5.2 Key Market Restraints:
5.2.1 High Cost of FISH Imaging Systems and Procedures
5.3 Key Market Opportunities:
5.3.1 Technological Advancements in Fluorescence in Situ Hybridization Imaging
5.4 Future Trends:
5.4.1 Automation and Digitalization of FISH Imaging Technique
5.5 Impact Analysis:
6. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - US Market Analysis
6.1 Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 – 2030
7. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Accessories
7.5.1 Overview
7.5.2 Accessories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cancer Diagnosis
8.3.1 Overview
8.3.2 Cancer Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Disease Diagnosis
8.4.1 Overview
8.4.2 Genetic Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Infectious Disease Diagnosis
8.5.1 Overview
8.5.2 Infectious Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Diagnostic Laboratories
9.3.1 Overview
9.3.2 Diagnostic Laboratories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization
9.4.1 Overview
9.4.2 Contract Research Organization: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical And Biotechnological Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnological Companies: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
10. Fluorescence In-situ Hybridization (FISH) Imaging Systems Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Euroclone SpA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 TissueGnostics GmbH
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Agilent Technologies Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Abnova Taiwan Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BioGenex Laboratories Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Leica Biosystems Nussloch GmbH
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 MetaSystems Probes GmbH
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Bio-View Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Thermo Fisher Scientific Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Applied Spectral Imaging
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 PerkinElmer Inc
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
Table 2. Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Table 4. Recent Inorganic Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
Table 5. Recent Organic Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
Table 6. Glossary of Terms, Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
List of Figures
Figure 1. US PEST Analysis
Figure 2. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2020 – 2030
Figure 5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Accessories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Cancer Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infectious Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Diagnostic Laboratories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Contract Research Organization: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Pharmaceutical And Biotechnological Companies: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
The List of Companies - U.S. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
- Euroclone SpA
- TissueGnostics GmbH
- Agilent Technologies Inc
- Abnova Taiwan Corp
- BioGenex Laboratories Inc
- Leica Biosystems Nussloch GmbH
- MetaSystems Probes GmbH
- Bio-View Ltd
- Thermo Fisher Scientific Inc
- Applied Spectral Imaging
- PerkinElmer Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Heart Transplant Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), End User (Hospitals, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Breath Analyzer Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Fuel Cell Technology, Semiconductor Sensor, Infrared Spectroscopy, and Others), Application (Drug Abuse Detection, Alcohol Detection, and Medical Applications), End User (Law Enforcement Agencies, Hospitals & Diagnostic Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Osteoarthritis Therapy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (TENS, Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others), Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals and Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Surgical Navigation Systems Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Optical Navigation System, Electromagnetic Navigation System, Hybrid Navigation System, Fluoroscopy Navigation System, CT-Based Navigation System, and Others), Application (Orthopedic, ENT, Neurology, Dental, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Skull Clamp Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Three-Pin Skull Clamp, Four-Pin Skull Clamp, and Two-Pin Skull Clamp), Application (Surgery and Medical Imaging), Material (Stainless Steel, Aluminum Alloy, Titanium, and Radiolucent), Accessories (Skull Pins, Headrest, and Others), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
Oct 2023
Teleradiology Services Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Deployment Type (Cloud-based, Web-based), Modality (MRI, CT-Scan, X-ray, Ultrasound, Others), Application (Musculoskeletal System, Gastroentrology, Cardiology, Oncology, Neurology, Others), End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Others), and Geography